Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Quanex Building Products CORPNX · Entity 5077 | SVP-Gen. Counsel & Secretary | November 01, 2019 | November 04, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Quanex Building Products CORP
Report date November 01, 2019 · Filed November 04, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 118,702.8355 |
Ending reported balance
After 2019-11-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-11-01 · Exercise / conversion · Acquired 32,400 · Balance 151,102.8355 F1: The stock options were exercised pursuant to a Rule 10b5-1 preset diversification program previously adopted by the reporting person in January 2019. Row 2 · 2019-11-01 · Sale · Disposed 32,400 · Balance 118,702.8355 F1: The stock options were exercised pursuant to a Rule 10b5-1 preset diversification program previously adopted by the reporting person in January 2019. F2: The price reported in Column 4 is a weighted price. These shares were sold in multiple transactions at prices ranging from $19.04 to $19.44, inclusive. The reporting person undertakes to provide to Quanex Building Products Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.21 · Expires 2019-12-02 | Direct | 0 |
Reported balance
After 2019-11-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-11-01 · Exercise / conversion · Disposed 32,400 · Balance 0 F1: The stock options were exercised pursuant to a Rule 10b5-1 preset diversification program previously adopted by the reporting person in January 2019. F3: The option becomes exercisable in one third increments annually beginning December 2, 2010. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options were exercised pursuant to a Rule 10b5-1 preset diversification program previously adopted by the reporting person in January 2019.
F2: The price reported in Column 4 is a weighted price. These shares were sold in multiple transactions at prices ranging from $19.04 to $19.44, inclusive. The reporting person undertakes to provide to Quanex Building Products Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3: The option becomes exercisable in one third increments annually beginning December 2, 2010.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 30, 2016 Filed Dec 1, 2016 21:31 UTC | Quanex Building Products CORP NX · Entity 5077 | GrantStock Options (Right to Buy) · Derivative | 28,300 | $0.00 Strike: $19.45 | $0.00 |
DisclosureSEC source: 0001127602-16-068827 · form4.xml · derivative · entry 2 DELANEY KEVIN P · CIK 0001255281 · SVP-Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,300 Underlying: Common Stock · 28,300 shares Expires 2026-11-30 F1 · derivative.exercise_date: The options vest in three equal annual installments beginning on November 30, 2017. Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 21:31 UTC | Quanex Building Products CORP NX · Entity 5077 | GrantCommon Stock | 9,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-068827 · form4.xml · nonDerivative · entry 1 DELANEY KEVIN P · CIK 0001255281 · SVP-Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,966.8355 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.